Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Klicek R, Sever M, Radic B, et al. Journal of Pharmacological Sciences 2008;108:7-17.
What it found
Fistulas between the colon and the skin closed faster with BPC-157 by either route, whether nitric oxide production was blocked or boosted. A steroid comparator made healing worse.
Limitations
Rats only, single research group. The title mentions clinical trials in inflammatory bowel disease, but no results from those trials have been published.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.